Qube Research & Technologies (QRT)
BCYC

Qube Research & Technologies (QRT)’s Bicycle Therapeutics BCYC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
+308,617
New +$1.76M ﹤0.01% 2343
2022
Q3 		– Sell
-124,696
Closed -$2.09M – 2513
2022
Q2 		$2.09M Buy
124,696
+115,890
+1,316% +$2.44M 0.02% 786
2022
Q1 		$386K Buy
+8,806
New +$411K ﹤0.01% 1653

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BCYC Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Bicycle Therapeutics (BCYC) in Q1 2026: 308,617 shares worth $1.43M. The stake represents ﹤0.01% of the portfolio and ranks #2343 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in BCYC as recently as Q2 2022.

Qube Research & Technologies (QRT) first reported a position in BCYC in Q1 2022 and has held it in 3 quarters since. The position peaked at $2.09M in Q2 2022. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Qube Research & Technologies (QRT) held 308,617 shares of Bicycle Therapeutics worth $1.43M as of Q1 2026.
  • Bicycle Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2343 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bicycle Therapeutics in Q1 2022 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Bicycle Therapeutics position peaked at $2.09M in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.